Hi 5

The Electronic Health Record (EHR) is receiving considerable attention as efforts by Providers and other sectors are underway to extending capabilities and value far beyond the original intent. In this episode we are diving into the topic of looking Beyond the EHR and clinical data to explore how healthcare organizations are wrapping solutions around the EHR and discuss trends that not many are thinking about. To help us dive into this topic, we’ve invited Friend of Vynamic, Shahrukh Tarapore, Arc Web Technologies Head of Engineering. For additional discussion, please contact us at Hi5@vynamic.com or share a voicemail at 1-888-VYNAMIC. Mindy McGrath, Healthcare Industry Learning Lead and Public Health Sector Advisor mmcgrath@vynamic.com Ryan Hummel, Executive rhummel@vynamic.com Mike Cottone, Director mcottone@vynamic.com

Clinical research development has long been targeted as an area of opportunity for pharma companies and investigator sites to find more efficient methods of adoption to drive success in commercializing a product. Friend of Vynamic, Amy Nordo joins us on this episode as we dive into the topic of Clinical Trials and how innovation is making its way into this critical function between a pharmaceutical company and the provider settings. Mindy discussed an article published by Kaiser Health News entitled “Death By 1,000 Clicks: Where Electronic Records Went Wrong.” The article provides an evaluation on the growth of the EHR industry as part of the Digital Revolution. https://khn.org/news/death-by-a-thousand-clicks/ Ryan discussed the news coming from the Cleveland Clinic of the first baby in North America delivered by a mother who received a uterus transplant from a deceased donor. https://health.clevelandclinic.org/for-the-first-time-in-north-america-woman-gives-birth-after-uterus-transplant-from-d

In 2017 the US spent an estimated 450 billion dollars on prescription drugs, about 12% of the total healthcare spending. With public and political uproar surrounding the life sciences industry pricing practices, we ask “why is drug pricing so complicated?”. In this episode, we’ll discuss drug pricing and more specifically explore the question of why prices are so high. The panel will discuss why drug pricing is so complicated and why proposed efforts to drive down costs may have unintended and undesired effects. Mike discussed a recent episode of the Verdict podcast in which they discussed a recent study regarding a machine learning algorithm that is able to predict heart attacks and death from heart disease with 90% accuracy, overtaking human practitioners. https://www.verdict.co.uk/machine-learning-predicts-heart-attacks/ Mindy discussed an article in Health Affairs entitled “The Administration’s Drug Rebate Reforms: Four Implementation Questions That Will Influence Wheth

Recent policy discussions have centered on the headline of Medicare for All. What does Medicare for All really mean? In short, the proposed policies mean many things to many people. In today’s episode, we are chatting about Medicare for All. Just in time for the kick off to primary season we will provide you with insight into the various proposals and the potential impacts. And stay tuned for our parting thought – its that thing that we have either read, heard or seen that we recommend to you. Source Links - Below, we've listed links to some of the stories and resources discussed on this show. https://en.wikipedia.org/wiki/Medicare_(United_States) https://en.wikipedia.org/wiki/Medicare_(United_States)#cite_note-1 https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/ReportsTrustFunds/downloads/tr2018.pdf https://www.kff.org/health-reform/poll-finding/kff-health-tracking-poll-january-2019/ Parting Thoughts Mike discussed a podcast series called “50 things t

Clinical Research is traditionally thought of as something belonging to Academic Medical Centers. In this episode you will hear more about why Clinical Research could and should be thought of as a strategic opportunity for any health system…community, academic or somewhere in between with guest, Shirley Trainor-Thomas, President and Principal Strategist at Phase Up Research. Source Links Below are the links to resources used for this episode: https://www.kubotaholdings.co.jp/en/ir/docs/20180517E.pdf http://www.ndcenterfornursing.org/wp-content/uploads/2013/02/Comparison-of-QI-EBP-and-Nursing-Research-Final-Document.pdf https://www.americannursetoday.com/quality-improvement-research/ Parting Thoughts Mindy recommended reading a recently published article from Modern Healthcare entitled “Why Prescription Drug List Price Matters.” The national conversation on drug list price has focused on the rebate structures that exist throughout the pharmacy supply chain. The article dives into an often-

Effective doctor-patient communication is a central clinical function in building a therapeutic doctor-patient relationship, which is the heart, and some would say the art of medicine. The panel is joined by colleague & guest, Deepa Mischler, to discuss the "how" around improving provider/patient interactions. And Friend of Vynamic, Mike Puchtler, VP Patient Experience at Christiana Care Health System. Mike’s focus is in driving excellence in patient experience at Christiana and we can’t think of a better guest to join us in this conversation. Source Links - Below, we've listed links to some of the stories and resources discussed on this show. http://www.medxm1.com/3-studies-show-patient-physician-interaction-affects-health-outcomes/ Parting Thoughts Mike discussed the development of an augmented reality headset by Apple and the variety of applications in the healthcare industry. https://apple.news/AE95GZR0uSrCgO2xPuKkyFw Mindy mentioned a recent report released by Medscape regarding physici

The strategic process of establishing a plan that maximizes the value of a brand has been practiced in similar fashion for, well, a long time. As the healthcare landscape changes, the question the team discussed is whether the brand planning process needs to change and what are the opportunities for improvement? We will discuss the practice that Life Science brand teams employ and generally, what is and isn’t working in the process. Mindy discussed a recent article published in Fierce Healthcare that announced the addition of Aetna and Ascension Health to the blockchain-focused alliance, Synaptic, that was initiated in 2018. https://www.fiercehealthcare.com/tech/aetna-ascension-join-blockchain-alliance-targeting-provider-directories Ryan discussed an interesting statistic published in Reuters regarding the high number of foreign born individuals employed in a variety of healthcare industry roles in the United States. https://www.reuters.com/article/us-health-professions-us-noncitizens/u-s-relies-heavi

The adoption of Electronic Health Records (EHR’s or EMR’s) has been, like many healthcare solutions, a revolution, with implementations happening in an extremely rapid fashion. And there are no plans on it slowing down. We discuss whether the Electronic Health Record is structured to be the ultimate gatekeeper in the industry. And joining us is guest, Chris Notti, Chief Information Strategist for Jefferson Health System joins us later in the show to dig into the good, bad and potential of EHRs. Below, we've listed links to some of the stories and resources discussed on this show. According to the Grand View Research group, the EHR market will total $33.41 billion —by 2025. The growth in market size indicates a dramatic increase. https://www.grandviewresearch.com/press-release/global-electronic-health-records-market There are visceral reactions to the use of EHRs – while many physicians understand the need for electronic health records, there are equally as many reasons why physici

- Below, we've listed links to some of the stories and resources discussed on this show. https://www.forbes.com/sites/bernardmarr/2018/05/21/how-much-data-do-we-create-every-day-the-mind-blowing-stats-everyone-should-read/ https://medium.com/@astorya_vc/digital-health-how-technology-could-reshape-health-insurance-9e066041826d https://www.healthedge.com/three-cs-digital-health-plan https://sph.unc.edu/cphm/how-has-digital-technology-changed-public-health/ https://davidleescher.wordpress.com/2016/11/28/five-public-health-needs-for-digital-health-technology/ https://getreferralmd.com/2018/01/future-healthcare-technology-advancements-2018/ https://medium.com/datavant/the-health-analytics-ecosystem-af13c2f0052

Blockchain is entering common discussions in the healthcare industry. This emerging technology offers tremendous hope to addressing some of the largest issues in the healthcare industry including efficiency & privacy. How soon can we expect to see this hit mainstream? The panel discusses timing and use cases for Blockchain technology across the healthcare system. Source Links - Below, we've listed links to some of the stories and resources discussed on this show. Parting Thoughts Mindy discussed the FDA’s interest in Artificial Intelligence and the agency’s initiation of their tech incubator for AI innovation. https://www.fda.gov/NewsEvents/Speeches/ucm605697.htm Ryan discussed a recent study that was published in Science Daily about the utilization of Artificial Intelligence in advancing the diagnosis of Alzheimer’s Disease. https://www.sciencedaily.com/releases/2018/11/181106104249.htm Mike referenced a recent NPR podcast episode about the balance of simplicity and complexity when it

In our fast-paced world, the healthcare industry is no different in its quest to quickly and successfully transition patients through their ‘contiuum of care’. Unfortunately, many times there is a knowledge gap between patient/caretaker and their respective provider, nurse, or physician. In this month’s Hi5 podcast, Vynamic tries to tackle these issues and discuss the differences between ‘lowercase a’ advocates, and “capital A” Advocacy to find some solutions to mitigate these risks. Special guest and friend of Vynamic, Dr. David Fajgenbaum, stops by to tell us his amazing story of advocacy around a disease that he was diagnosed with; one that almost killed him. 1. https://www.ncbi.nlm.nih.gov/pubmed/24841071 2. http://www.commonwealthfund.org/~/media/files/publications/case-study/2009/jun/1278_mccarthy_kaiser_case_study_624_update.pdf. 3. https://www.scitechnol.com/peer-review/patient-navigators-as-essential-members-of-the-healthcare-team-a-review-of-the-lite

The rise of the empowered consumer is a trend healthcare organizations are trying to better understand in the context of putting the consumer in the center of healthcare. But how real is consumerism in the industry and has it had an impact? Ryan, Mindy, Mike and guest Kristen Sherman debate what is working and what is not when it comes to empowering individuals. And stay tuned to the episodes parting thought. Below, we've listed links to some of the stories and resources discussed on this show. https://www.kff.org/health-costs/report/2017-employer-health-benefits-survey/view/print/ http://www.healthleadersmedia.com/finance/consumerism-growing-rapidly-putting-more-demands-providers https://www.strategyand.pwc.com/media/file/The-birth-of-the-healthcare-consumer.pdf https://medcitynews.com/2015/11/patient-healthcare-consumer/ https://www.wsj.com/articles/can-consumers-be-smart-health-care-shoppers-1491962640 https://www.realclearhealth.com/articles/2018/05/03/empowered_patients_are_the_future_of_health_care_1107

Mindy, Ryan and Mike discuss the powerful trends are at work globally – forcing changes in how healthcare will be conceived and delivered in the future. In an interview, Sylvia Twersky, PhD, Temple University, discusses the relevant and intriguing trends across the healthcare industry. And as always, stay tuned for the end of the show’s parting thoughts. Sources: https://www.chcs.org/highlight/accountable-care-organizations-in-2016-private-and-public-sector-growth-and-dispersion/ https://www.pcpcc.org/resource/national-scorecard-and-compendium-payment-reform https://bipartisanpolicy.org/topics/health/ https://www.kff.org/health-costs/report/2017-employer-health-benefits-survey/ https://rockhealth.com/research/#data https://www.kff.org/private-insurance/report/medical-debt-among-people-with-health-insurance/ http://theonebrief.com/cracking-the-code-of-rising-health-costs/ http://www.healthleadersmedia.com/health-plans/amazon-pouring-gasoline-fire-health-plans-must-respond?utm_sour

Disruptive innovation are common terms being used to describe the state of the healthcare market. Looking beyond the hype, Vynamic discusses the management framework of Disruptive Innovation and why it is difficult to achieve in the colossal healthcare industry. And as always, stay tuned for the end of the show’s parting thoughts.

With Amazon diving head first into the healthcare market it is no longer a question of will they but what this titanic organization will do to disrupt the healthcare industry. Mindy, Ryan and Mike debate how disruptive Amazon’s entry into the market may be and which sectors could be most impacted.

The CMS and FDA have been actively promoting proposed rule changes, rolling out new programs and adopting new technologies in an effort to advance the US healthcare system and modernize their agencies. From efforts to increase transparency, waivers to experiment and adoption of Artificial Intelligence, these agencies are taking action. The team discusses some of these activities and what the impact could be to the healthcare industry.

The healthcare services industry is going through rapid change as a slew of giant companies propose deals that may result in new value propositions to healthcare stakeholders. The panel discusses the moves being made and whether vertical integrations will result in similar outcomes.

MACRA represents a transformative shift in the direction of physician payment, and will impact strategy across the provider community. CMS contends that parts of MACRA are working and parts need a redo. Do Mindy and Ryan agree? Is MACRA achieving its intended goals of improving quality and lowering costs? They will discuss the recently concluded “transition” year and what to expect in 2018. And as always, stay tuned for the end of the show’s parting thoughts.

Mindy and Ryan are joined by friends and colleagues, Karen Baldry & Chris Savage to debate why new medicines matter. With novel therapies addressing complex disease states that come with significant price points, the panel discusses why the launch of a new product is critical for life science organizations. The panel discusses what it means that an increasing number of launches fall into specialty markets and how launch practices are shifting to reflect new dynamics and complexity. And as always, stay tuned for the end of the show’s parting thoughts.

While much of the attention this year has focused on activity in the beltway, healthcare technology continues to introduce innovative and disruptive solutions and services that could offer transformational movement in the way that healthcare is conceived, delivered, accessed and reimbursed. Mindy and Ryan discuss whether tech can heal the healthcare system with colleagues, Chrisna Govin and Sam Farmer. And as always, stay tuned for the end of the show’s parting thoughts.